The SafeLife Project - Micro LDRI™
Breast cancer is one of the most pervasive killers in the U.S. today. From 15 to 30 percent of the 44,000 women diagnosed with breast cancer each year do not survive. There is a great need for non-invasive cancer diagnosis and treatment techniques, especially for breast cancer. Most current technologies are invasive and present significant problems such as secondary cancer exposure and long diagnostic/treatment time. Low image resolution is another concern, which is aggravated by human errors and leads to the misinterpretation of results.
Operation Micro LDRI™ is a breakthrough medical technology invented, developed and patented by our company. Its main application is the safer diagnosis and treatment of patients with soft tissue tumors during early stages of tumor development, where existing methods do not produce adequate results. This technology allows doctors to work with three-dimensional images, permitting physicians to scan soft tissue organs with a degree of accuracy unattainable with traditional techniques. Micro LDRI™ is a hypersensitive receptor technology coupled with low-radiation radioactive tracers. It allows scanning of soft tissues with less than one-tenth the radiation dosage required by traditional diagnostic methods. This will permit more frequent and therefore more effective preventive checks for tumors. In addition, this technology offers a thousand-fold reduction in risk typical of higher radiation exposure associated with conventional methods.
|
|
HDsems™
